搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
8 天
Prognostic Markers and Targeted Therapies for Renal Cell Carcinoma
Management of advanced renal cell carcinoma remains a persistent clinical challenge with high morbidity and mortality for a large proportion of patients. Until recently, available medical ...
Targeted Oncology
2 天
Top 10 Genitourinary Cancer Advances in 2024
In January 2024, the FDA approved erdafitinib (Balversa) for adult patients with locally advanced or metastatic urothelial ...
Cure Today
2 天
Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors
Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...
10 天
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
Renal & Urology News
27 天
No OS Benefit Seen With Avelumab Plus Axitinib in Advanced RCC
Avelumab plus axitinib did not improve overall survival in the overall population or in patients with PD-L1-positive disease.
Businessworld
8 小时
crouching tiger hidden dragon english dub
INR:7752. crouching tiger hidden dragon english dub National Health Commission: Further strengthen laboratory biosafety supervision and ...
Targeted Oncology
11 天
Standard Belzutifan Dose Equally Effective as Higher Dose in ccRCC
In an interview with Targeted Oncology, Jaime Merchan, MD, delved into data from the LITESPARK-013 trial evaluating ...
Pharmaceutical Technology
4 天
Zanzalintinib fumarate by Exelixis for Hypopharyngeal Cancer: Likelihood of Approval
Zanzalintinib fumarate is under clinical development by Exelixis and currently in Phase III for Hypopharyngeal Cancer.
来自MSN
9 天
Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy
US-based biotechnology company Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈